ClinicalTrials.Veeva

Menu

Effects of Virtual Reality on Brain Hemodynamic Activity in Chronic Pain

A

Acibadem University

Status

Completed

Conditions

Chronic Pain
Virtual Reality
Rheumatoid Arthritis

Treatments

Other: Immersive virtual reality
Other: Non-immersive virtual reality

Study type

Interventional

Funder types

Other

Identifiers

NCT06154850
ATADEK 2022-14/06

Details and patient eligibility

About

Virtual reality systems have been applied in recent years to reduce pain intensity and fear of movement in individuals with acute and chronic pain. The main mechanism of virtual reality methods in pain control is to provide the effect of distraction from pain. Virtual reality systems allow the individuals to feel themselves in a different environment and shift their attention to the game they are playing or the virtual world created rather than the pain they feel. This is thought to be the main mechanism of pain control. However, the cortical mechanism of the reduction in pain caused by virtual reality methods, especially in individuals with chronic pain, has not been fully elucidated.

It is predicted that the integration of virtual reality methods into treatment protocols will gradually increase by time, especially as a result of the reflection of technological developments in clinical practice. At this point, fNIRS, which enables the assessment of the functionality of brain areas during movement, has the potential to reveal the response of the effect provided by virtual reality technology in the prefrontal cortex.

The aims of our study were to examine brain hemodynamic activity during the experience of non-immersive and immersive virtual reality environments and the change in pain intensity after virtual reality applications in individuals with rheumatic diseases with chronic pain.

Enrollment

15 patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with rheumatoid arthritis,
  • Right hand dominant,

Exclusion criteria

  • A history of acute pain up to 3 days prior to the date of evaluation,
  • Any psychiatric and neurological diagnosis,
  • Have a cognitive problem that prevents them from adapting to the working procedure,
  • Using centrally acting medications and anti-depressants.
  • Presence of neuropathic pain,
  • Presence of vision or hearing problems,
  • Any psychiatric and neurological diagnosis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

15 participants in 2 patient groups

Immersive Virtual Reality
Experimental group
Description:
Individuals will wear the headset for 10 minutes while playing NatureTrek application
Treatment:
Other: Immersive virtual reality
Non-immersive Virtual Reality
Active Comparator group
Description:
Individuals will watch a video including scenes from NatureTrek application for 10 minutes.
Treatment:
Other: Non-immersive virtual reality

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems